Comparison

Imiquimod European Partner

Item no. TMO-T0134-500mg
Manufacturer TargetMol
CASRN 99011-02-6
Amount 500 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 g 1 mL 200 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Citations 1. Gibson SJ, et al. Cell Immunol. 2002 Jul-Aug;218(1-2):74-86.
Smiles C(C(C)C)N1C=2C=3C(N=C(N)C2N=C1)=CC=CC3
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias R 837,IMQ,S-26308
Shipping Condition Cool pack
Available
Manufacturer - Targets
Autophagy|||HSV|||TLR|||SARS-CoV
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
240.3
Description
Imiquimod (R 837) is an immune response modifier that acts as a toll-like receptor 7 agonist.
Pathways
Microbiology/Virology|||Immunology/Inflammation|||Autophagy
Bioactivity
Imiquimod is an immune response modifier that acts as a toll-like receptor 7 agonist. Imiquimod is commonly used topically to treat warts on the skin of the genital and anal areas. Imiquimod does not cure warts, and new warts may appear during treatment. Imiquimod does not fight the viruses that cause warts directly, however, it does help to relieve and control wart production. Miquimod is also used to treat a skin condition of the face and scalp called actinic keratoses and certain types of skin Y called superficial basal cell carcinoma.
Receptor
TLR7; TLR8

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close